Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Big-Pharma Drugs to Dominate Cancer Event
Barron's
Friday, June 3, 2011 - 6:48pm
tags:
ASCO, cancer, Pfizer, Roche, Bristol-Myers Squibb, Eli Lilly, Merck, Ariad Pharmaceuticals, Novartis
Forest Labs speeds up stock repurchase plan
Yahoo/AP
Friday, June 3, 2011 - 11:36am
tags:
stock buyback, Forest Labs
A Fight Is Brewing Over Generic Viagra
Barron's
Friday, June 3, 2011 - 11:33am
tags:
generics, Viagra, Watson Pharmaceuticals, Pfizer
Endo Pharmaceuticals sued by sales reps
Reuters
Friday, June 3, 2011 - 10:50am
tags:
Endo, drug reps, overtime lawsuits
Impax Laboratories Confirms Patent Suit Relating To Generic Detrol® Immediate-Release 1 Mg And 2 Mg Tablets
TheStreet.com
Friday, June 3, 2011 - 10:49am
tags:
patents, Impax, Detrol, Pfizer
7 Dirt-Cheap Takeover Targets in Biotech
Seeking Alpha
Friday, June 3, 2011 - 10:44am
tags:
M&A, Acorda Therapeutics, Antares, Alnylam, BioSante, Catalyst, Inhibitex, Keryx
Roche’s Tarceva Stalls Lung Cancer in Late-Stage Study
Yahoo/AP
Friday, June 3, 2011 - 10:42am
tags:
Roche, Tarceva, lung cancer
Pharmasset rises as analyst says hepatitis C drug could be approved in 2014, raises target
Yahoo/AP
Friday, June 3, 2011 - 10:40am
tags:
Pharmasset, hepatitis C
Orexigen puts US obesity drug development on hold, cites FDA demands, shares skid in premarket
Yahoo/AP
Friday, June 3, 2011 - 9:19am
tags:
FDA, Orexigen, obesity, Contrave
New GSK lung drug hits most targets in two studies
Yahoo/Reuters
Friday, June 3, 2011 - 9:18am
tags:
GSK, Relovair, Theravance, COPD
A New Pricing Game for Drugmakers in Europe
Bloomberg Businessweek
Friday, June 3, 2011 - 9:16am
tags:
drug pricing, Europe
Pharma Needs an Innovation Intervention
Businessweek
Thursday, June 2, 2011 - 11:35pm
tags:
innovation, patents
Johnson & Johnson Hid Antibiotic Levaquin Risk, Lawyer Says
Bloomberg
Thursday, June 2, 2011 - 11:32pm
tags:
Levaquin, antibiotics, JNJ
Blood Pressure Drugs Do Not Raise Cancer Risk
Pharmalot
Thursday, June 2, 2011 - 11:31pm
tags:
antihypertensives, cancer
United Therapeutics: Growth Engine for Cardiovascular Diseases
Seeking Alpha
Thursday, June 2, 2011 - 11:30pm
tags:
United Therapeutics
Abbott in Settlement Talks on Depakote Marketing, U.S. Says
Bloomberg
Thursday, June 2, 2011 - 11:29pm
tags:
Abbott Laboratories, Depakote, settlements
J&J Returns Diabetes Drug Rights
Yahoo/Zacks.com
Thursday, June 2, 2011 - 11:28pm
tags:
JNJ, diabetes, Diamyd Medical
Analyst says major pharma stocks have rallied prematurely ahead of spate of generic launches
Yahoo/AP
Thursday, June 2, 2011 - 1:40pm
tags:
generics
Mylan Receives Approval for Generic Version of Effexor XR® Capsules
PR Newswire
Thursday, June 2, 2011 - 1:38pm
tags:
generics, Mylan, Effexor
Teva to pay Cephalon execs golden parachutes
Globes, Israel
Thursday, June 2, 2011 - 1:37pm
tags:
Teva Pharmaceuticals, Cephalon, executive pay

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.